Lucid Diagnostics LUCD
NASDAQ LUCD
$0.96 -0.05 (-4.95%)
As of: Aug 20, 2026 · 3:59 PM EDT

Lucid Diagnostics (LUCD) Total Non-Current Liabilities (2022 - 2026)

Lucid Diagnostics' (LUCD) quarterly Total Non-Current Liabilities came in at $30.1 million in Q1 2026, up 459.94% YoY from $5.4 million in Q1 2025, and up 446.02% on a QoQ basis from $5.5 million in Q4 2025.

Lucid Diagnostics (LUCD) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Lucid Diagnostics (LUCD) has 5 years of Total Non-Current Liabilities data on file, last reported at $30.1 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 459.94% year-over-year to $30.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.1 million (up 459.94% YoY) and the FY2025 annual result came in at $5.5 million, down 18.07% from the prior year.
  • Total Non-Current Liabilities climbed to $30.1 million in Q1 2026, from $5.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $30.1 million in Q1 2026 to a low of $1.3 million in Q2 2022.
  • A 5-year average of $9.4 million and a median of $6.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities jumped 1132.84% — and 2024, when it plunged 62.59%.
  • Tracing LUCD's Total Non-Current Liabilities over 5 years: stood at $1.3 million in 2022, then jumped by 1119.27% to $15.6 million in 2023, then slumped by 56.98% to $6.7 million in 2024, then slipped by 18.07% to $5.5 million in 2025, then jumped by 446.02% to $30.1 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $30.1 million (Q1 2026), $5.5 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 9.07 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.44 Bn
10 Lucid Diagnostics 175.80 Mn 142.40 Mn 55,000.00 4.52 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.52 Mn
Mar 31, 2026 30.08 Mn
Dec 31, 2025 5.51 Mn
Sep 30, 2025 5.06 Mn
Jun 30, 2025 5.51 Mn
Mar 31, 2025 5.37 Mn
Dec 31, 2024 6.72 Mn
Sep 30, 2024 6.06 Mn
Jun 30, 2024 6.93 Mn
Mar 31, 2024 7.01 Mn
Dec 31, 2023 15.63 Mn
Sep 30, 2023 16.20 Mn
Jun 30, 2023 15.81 Mn
Mar 31, 2023 12.32 Mn
Jun 30, 2022 1.28 Mn
Mar 31, 2022 1.46 Mn